Characteristics of patients admitted to hospital for myocardial infarction France with respect to left ventricular function: Result of the USIK study;Caracteristiques des patients hospitalises en France pour infarctus du myocarde en fonction du degre d'atteinte de leur fonction ventriculaire gauche: Resultats de l'etude USIK

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue 11, 1997, Pages 1485-1492

  Vaur, L ^a   Danchin, N ^b   Genes, N ^a   Renault, M ^a   Etienne, S ^a   Ferneres J ^c   Cambou, J P ^c  

^a Laboratoires Roussel   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY CARE UNIT; FEMALE; FRANCE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE DIAGNOSIS; CLINICAL TRIAL; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CORONARY CARE UNITS; FEMALE; FRANCE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030716453     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sutton M, Pfeffer MA, Plappert T et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 1994 ; 89 : 68-75.
2. Van Reet RE, Quinones MA, Poliner LR et al. Comparison of two-dimensional echocardiography with gated radionuclide ventriculography in teh evaluation of global and regional left ventricular function in acute myocardial infarction. J Am Coll Cardiol 1984 ; 3 : 243-52.
3. Nishimura RA, Tajik AJ, Shub C, Miller FA, Ilstrup DM, Harrison CE. Role of two-dimensional echocardiography in the prediction of in-hospital complications after acute myocardial infarction. J Am Coll Cardiol 1984 ; 4 : 1080-7.
4. Kan G, Visser CA, Koolen JJ, Dunning AJ, Short and long term predictive value of admission wall motion score in acute myocardial infarctions : a cross sectional echocardiographic study of 345 patients. Br Heart J 1986 ; 56 : 422-7.
5. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol 1967 ; 20 : 457-62.
6. Lee KL, Woodlief LH, Topol EJ et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction : results from an international trial of 41.021 patients. Circulation 1995 ; 91 : 1659-68.
7. Béard T, Carrié D, Pachins B, Jaillais P, Delay M, Bernadet P, Suivi àun an de 328 patients atteints d'infarctus du myocarde. Arch Mal Cuœur 1994 ; 87 : 869-73.
8. Nicod P, Gilpin E, Dittrich H et al. Influence on prognosis and morbidity of left ventricular ejection fraction witn and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol 1988; 61 : 1165-71.
9. The Multicenter Postinfarction Research Group. Risk stratification and survival after acute myocardial infarction. N Engl J Med 1983 ; 309 : 331-6.
10. Kober L, Torp-Pedersen C, Corlsen J, Videbaek R, Egeblad H. An echocaraiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multicenter studies (as used in me TRACE study). Eur Heart J 1994 ; 15 : 1616-20.
11. Stevenson R, Ranjadaylan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. Br Med J 1993 ; 307 : 349-53.
12. Cleland JGF. ACE inhibitors for myocardial infarction : how should they be used ? Eur Heart J 1995 ; 16 : 153-9.
13. The Beta-Blocker Pooling Project research group. The Beta-Blocker Pooling Project (BBPP) : subgroup findings from randomized trials in post-infarction patients. Eur Heart J 1988 ; 9 : 8-16.
14. Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecamide or placebo : the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991 ; 324 : 781-8.
15. The Danish study group on verapamil in myocardial infarction. Effects of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT-II).Am J Cardiol 1990 ; 66 : 779-85.
16. Cambou JP, Richard JP, Arveiler D et al. Les premiers enseignements du projet MONICA. Rev Prat 1990 ; 40 : 2247-60.
17. Le groupe de travail «épidémiologie et prévention » de la société française de cardiologie. Fréquence et conditions d'hospitalisation des infarctus récents du myocarde en France : l'enquète nationale ENIM 84. Arch Mal Cœur 1987 ; 80 : 1853-63.
18. Monassier JP, Hanania G, Khalifé K, Frelon JH, Boureux C, Fournier PY. Stratégies thérapeutiques à la phase aiguë de l'infarctus du myocarde : résultats du registre STIM 93. Arch Mal Coeur 1996 ; 89 : 281-9.
19. Boissel JP, Némoz C, Leizorovicz A, Gillet J. La prescription médicamenteuse dans le postinfarctus : résultats de l'EPPI II. Arch Mal Cœur 1995 ; 88 : 1261-6.
20. Colin C, Toselli A, Delahaye F et al. Prise en charge de l'infarctus du myocarde dans la région Rhône-Alpes : existe-t-il une variation des pratiques ? Arch Mal Cœur 1995 ; 88 : 307-13.
21. Jarry G, Richard JL, Hermida JS et al. EPIM : enquête sur l'infarctus du myocarde en Picardie. Arch Mal Cœur 1990 ; 83 : 1367-74.
22. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989 ; 2 : 358-67.
23. Berning J, Hoilund-Carlsen PF, Nielsen GG, Gadsboll N, Marvinq J, Jensen BH. Critical reappraisal of bedside echocardiographic parameters for estimation of left ventricular ejection fraction in acute myocardial infarction. Am J Noninvas Cardiol 1992 ; 6 : 269-78.
24. Berning J, Steenegaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol 1900 ; 65 : 567-76.
25. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993 ; 342 : 821-8.
26. Moye LA for the SAVE investigators. Rationale and design of a trial to assess patient survival and ventricular enlargement after myocardial infarction. Am J Cardiol 1991 ; 68 : D 70-D 79.
27. Kober L, Torp-Pedersen C. Clinical characteristics and mortality of patients screened for entry into the TRAndolapril Cardiac Evaluation (TRACE) study. Am J Cardiol 1995; 76: 1-5.
28. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992 ; 327 : 669-77.
29. Kober L, Torp-Pedersen C, Carlsen JE et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardiaf infarction. N Engl J Med 1995 ; 333 : 1670-6.
30. Ball SG, Hall AS, Murray GD. ACE inhibition, atherosclerosis and myocardial infarction. The AIRE study in practice. Eur Heart J 1994 ; 15 (suppl B) : 20-5.